ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
96 hedge funds and large institutions have $37.8M invested in Endocyte, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $47.5M → $37.8M (-$9.68M)
Holders
96
Holding in Top 10
–
Calls
$167K
Puts
$46K
Top Buyers
| 1 | +$407K | |
| 2 | +$365K | |
| 3 | +$311K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$267K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$212K |
Top Sellers
| 1 | -$2.69M | |
| 2 | -$1.2M | |
| 3 | -$399K | |
| 4 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$307K |
| 5 |
SIM
Spark Investment Management
New York
|
-$230K |